Oral vs. Inhaled Cannabis for Multiple Sclerosis: Balancing Safety

Managing symptoms associated with multiple sclerosis (MS) has led many patients to explore cannabis as a therapeutic adjunct. Anecdotal clinical experience, as well as observational studies, suggest that certain cannabinoids can modulate muscle spasticity and improve nighttime rest. However, transitioning from the inhaled route to the oral route is neither trivial nor free of risk. Understanding the pharmacokinetic differences between the two is essential to avoid unexpected adverse effects and ensure safe dosing.

Fundamental differences between inhaled and oral routes

Smoking or vaporizing has historically been the most common method, primarily due to its rapid onset. Effects appear within minutes, allowing for immediate titration: if the user feels the dose is insufficient, they can repeat; if it is excessive, the effects subside quickly as it is metabolized. Furthermore, this route avoids the ingestion of plant combustion byproducts.

Conversely, oral administration introduces cannabis into the digestive system. Here lies the primary challenge: overdosing. Because there is no pulmonary barrier to limit rapid entry into the bloodstream, and due to slow and incomplete intestinal absorption, it is easy to underestimate the potency of an oral product. A patient accustomed to smoking may ingest an oral amount that, after being metabolized in the liver (first-pass effect), proves much more potent than expected.

The role of diet and individual physiology

The pharmacokinetics of oral cannabis are notably erratic. Factors such as biological sex, body composition, and hormonal status influence how cannabinoids are absorbed. However, the most determining factor is often what is in the stomach.

Cannabinoids are lipophilic; they require fat to be absorbed efficiently. Ingesting a tincture or oil with fatty foods (whole milk, butter, chocolate) increases bioavailability drastically compared to taking it on an empty stomach. This means that two identical doses of the same product can have very different clinical effects depending on the preceding breakfast or dinner.

Artisanal preparation: tinctures and oils

In the context of harm reduction, it is crucial to understand how homemade oral products are obtained. A classic tincture involves macerating cannabis in ethyl alcohol (preferably absolute or pharmaceutical grade) for a week in cold, dark conditions, stirring daily to facilitate extraction. After filtering with materials like paper coffee filters, one obtains a liquid that can be processed multiple times.

On the other hand, oil usually refers to two distinct processes: dissolving the plant in vegetable oil (olive or sunflower) or reducing the tincture until the solvent evaporates. In the latter case, a dark paste with a high concentration of cannabinoids is obtained. The key difference is that vegetable oils dilute the initial potency more than alcohol, but both methods are artisanal and lack standardization.

The uncertainty of concentration

The central problem with these homemade preparations is the impossibility of knowing the final concentration with certainty. This depends on the type of plant (varieties with different profiles of THC, CBD, and other minor cannabinoids) and the variable efficacy of the extraction method used.

There is no direct equivalence between grams of dried flower and milliliters of tincture or oil. The same amount of product can have different effects on different people due to this intrinsic variability. For this reason, public health organizations and specialized NGOs strongly recommend quantitative analysis of samples via mass spectrometry to determine the exact concentration before therapeutic use.

Harm reduction strategies

When deciding to use oral cannabis, strict measures must be adopted to minimize dangers:

1. Slow titration: Start with minimal doses (for example, one drop or one-third of the usual teaspoon) and wait at least two hours before considering a repeat dose. Oral absorption is slow; effects can take between 30 minutes and several hours to manifest fully.
2. Dietary control: Establish a fixed routine for consumption, always accompanied by foods with a known fat content, to reduce the variability of the response.
3. Sublingual route as a bridge: Placing oil or tincture under the tongue allows for direct absorption through the mucous membranes into the systemic circulation, bypassing the liver and reducing gastrointestinal effects. Although absorption remains individual, it offers a more predictable profile than pure oral ingestion.
4. Avoid mixing: Do not combine oral cannabis with other central nervous system depressants (alcohol, benzodiazepines) without strict medical supervision, as they potentiate sedative effects and the risk of accidents.

Editorial closing: toward conscious pharmacology

The use of cannabis for conditions like multiple sclerosis must be approached from a scientific and prudent perspective. The oral route, while offering advantages for patients who cannot smoke or who seek prolonged effects, introduces pharmacokinetic complexities that require greater vigilance. Artisanal preparation has its place in contexts of limited access, but it never replaces the need to know the product’s potency.

At Psiconáutica.org, we always promote a culture based on evidence and harm reduction. Recognizing the limitations of homemade methods and valuing options like laboratory analysis or the sublingual route are essential steps to transform an anecdotal practice into safe therapeutic management. The mental and physical health of the MS patient deserves to be protected not only by the potency of the drug, but by the knowledge surrounding its administration.

Remember that every organism is unique: what works for one may be excessive for another. Patience, observation of effects, and consultation with healthcare professionals are the best tools for navigating this therapeutic territory.